ORTX

Orchard Therapeutics plc American Depositary Shares

Delisted

ORTX was delisted on the 23rd of January, 2024.

50 hedge funds and large institutions have $30.2M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-11
Holders Change %
-18.03%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
7
Reduced
13
Closed
17
Calls
$10K
Puts
Net Calls
+$10K
Net Calls Change
-$1K
Name Holding Trade Value Shares
Change
Shares
Change %
HWAM
51
Hennion & Walsh Asset Management
New Jersey
-$117K -16,418 Closed
IC
52
Ikarian Capital
Texas
-$110K -15,561 Closed
Legal & General Group
53
Legal & General Group
United Kingdom
-$58K -8,142 Closed
Goldman Sachs
54
Goldman Sachs
New York
-$26K -3,679 Closed
HF
55
HRT Financial
New York
-$18K -2,599 Closed
RE
56
RBC Europe
United Kingdom
-$14K -1,950 Closed
VPIM
57
Vanguard Personalized Indexing Management
California
-$12K -1,626 Closed
Two Sigma Advisers
58
Two Sigma Advisers
New York
-$11K -1,590 Closed
BFM
59
Boothbay Fund Management
New York
-$11K -1,493 Closed
US Bancorp
60
US Bancorp
Minnesota
-$7K -924 Closed
ACM
61
Aquatic Capital Management
Illinois
-$3K -380 Closed
QT
62
Quantbot Technologies
New York
-$2K -330 Closed
SPIA
63
Steward Partners Investment Advisory
New York
-$1K -100 Closed